In an industry-first, the company Synchron and Mount Sinai Hospital in New York have enrolled their first human patient in a U.S. clinical trial called COMMAND to evaluate an endovascular ...

AUSTIN, Texas, October 26, 2026--(BUSINESS WIRE)--Paradromics Inc., a neurotechnology company developing high-data-rate brain-computer interfaces to restore and enhance human capabilities, today ...

Neuvotion is advancing AI-guided neuromodulation and brain–computer interface (BCI) technologies based on its founder’s groundbreaking research to create brain–body interfaces that restore movement, ...

Unresponsive ICU patients in a new Columbia study were able to raise and lower the frequency of a beeping tone with their minds, via noninvasive EEG electrodes that recorded and translated their brain ...

Working with clinical researchers at Cleveland Clinic Abu Dhabi, the brain-computer interface company takes next step toward bringing transformative neurotechnology to patients worldwideNEW YORK, Oct.

A new brain implant stands to transform human-computer interaction and expand treatment possibilities for neurological conditions such as epilepsy, spinal cord injury, ALS, stroke, and ...

New York-based Precision Neuroscience, a brain-computer interface (BCI) company, closed an oversubscribed $250 million Series D financing round, bringing its total capital raise to $430 million.

UCLA engineers have developed a wearable, noninvasive brain-computer interface system that utilizes artificial intelligence as a co-pilot to help infer user intent and complete tasks by moving a ...

Fabricated as a single chip, the new implant is orders of magnitude faster and smaller than today’s state-of-the-art brain-computer interfaces, offering an opportunity for more efficacious treatment ...